omicron omicron
Stories About

omicron

Travelers at Shanghai Hongqiao Railway Station in Shanghai, China on Dec. 12. China's public health officials say up to 800 million people could be infected with the coronavirus over the next few months. Qilai Shen/Bloomberg via Getty Images hide caption

toggle caption
Qilai Shen/Bloomberg via Getty Images

COVID spreading faster than ever in China. 800 million could be infected this winter

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/1143002538/1143002539" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

New COVID variants that are highly immune evasive have overtaken BA.5 to dominate in the U.S. Experts warn this means more reinfections and a possible winter surge. Spencer Platt/Getty Images hide caption

toggle caption
Spencer Platt/Getty Images

An electron microscope image shows a SARS-CoV-2 particle isolated in the early days of the pandemic. It's been nearly a year since omicron was first detected, and scientists say this branch of the coronavirus family tree is still thriving. NIAID/NIH via AP hide caption

toggle caption
NIAID/NIH via AP

Omicron keeps finding new evolutionary tricks to outsmart our immunity

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/1129196088/1131279359" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
Scott Olson/Getty Images

Sikhulile Moyo, the laboratory director at the Botswana-Harvard AIDS Institute and a research associate with the Harvard T.H. Chan School of Public Health, headed the team that identified the omicron variant. Leabaneng Natasha Moyo hide caption

toggle caption
Leabaneng Natasha Moyo

The new booster shot would be an update to Pfizer's current version of the shot, which was designed for the original strain of the coronavirus. Nam Y. Huh/AP hide caption

toggle caption
Nam Y. Huh/AP

The FDA is trying to make "bivalent" COVID vaccines, which target two different antigens, available as soon as September. Robyn Beck/AFP via Getty Images hide caption

toggle caption
Robyn Beck/AFP via Getty Images

Reformulated COVID vaccine boosters may be available earlier than expected

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/1113615330/1113615331" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

A Covid-19 testing site stands on a Brooklyn street corner in April. Spencer Platt/Getty Images hide caption

toggle caption
Spencer Platt/Getty Images

A new dominant omicron strain in the U.S. is driving up cases — and reinfections

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/1110804098/1110804747" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

A nurse fills a syringe with a COVID-19 vaccine in the Staten Island borough of New York on April 8, 2021. The Food and Drug Administration on Thursday recommended that COVID booster shots be modified to better match more recent variants of the coronavirus. Mary Altaffer/AP hide caption

toggle caption
Mary Altaffer/AP

A syringe is prepared with the Pfizer COVID-19 vaccine at a vaccination clinic in Chester, Pa., on Dec. 15, 2021. Pfizer says tweaking its COVID-19 vaccine to better target the omicron variant is safe and boosts protection. Matt Rourke/AP hide caption

toggle caption
Matt Rourke/AP

The omicron variant, though much more contagious than the delta strain, is still prevalent in the U.S. but is less likely than delta to cause long COVID, according to a new study. Spencer Platt/Getty Images hide caption

toggle caption
Spencer Platt/Getty Images

Omicron poses about half the risk of long COVID as delta, new research finds

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/1094655028/1105790922" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

A positive result on a home COVID test. If you catch it once, can you catch it again? Turns out the answer is: Yes. Jakub Porzycki/NurPhoto via Getty Images hide caption

toggle caption
Jakub Porzycki/NurPhoto via Getty Images

Journalists and politicians mingled at an afterparty following the White House Correspondents Dinner on April 30. Based on COVID cases among attendees at the main event, SARS-CoV-2 was mingling as well. Amanda Andrade-Rhoades/for The Washington Post via Getty Images hide caption

toggle caption
Amanda Andrade-Rhoades/for The Washington Post via Getty Images

A woman wears a face shield to protect against COVID-19 at a taxi stand in Soweto, South Africa, where an omicron variant is causing a COVID-19 surge. Denis Farrell/AP hide caption

toggle caption
Denis Farrell/AP

If you've had omicron before, are you safe from infection by the new variants?

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/1096412194/1096720005" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

A medical worker administers tests at a Covid-19 testing site in New York City. New York City and other places in the Northeast are seeing an uptick in infection numbers. Spencer Platt / Getty Images hide caption

toggle caption
Spencer Platt / Getty Images

A case of COVID-19 brought 12-year-old Harry Nelson to the emergency room in Syracuse, N.Y., where cases are surging, His mother, photographer Paula Nelson, says he first had mild symptoms — just a headache — but later ran a high fever and began vomiting, which meant he couldn't keep down fever-relief meds. At the ER, he needed saline to rehydrate, Tylenol for his fever and meds to stop vomiting. Paula Nelson for NPR hide caption

toggle caption
Paula Nelson for NPR

A pop-up clinic inside Los Angeles International Airport offered free vaccinations and boosters for holiday travelers last December. A new round of vaccinations may be needed before next winter. FREDERIC J. BROWN/AFP via Getty Images hide caption

toggle caption
FREDERIC J. BROWN/AFP via Getty Images

Advisers to FDA weigh in on updated COVID boosters for the fall

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/1091242252/1091308734" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript